Biotech Values

[floblu14]

MNTA European/U.S. Patent Applications Update for RMF - Plus MNTA Overview of their Patent Estate -

1. METHODS OF GLYCOPROTEIN ANALYSIS 2016-11-10

Abstract: Characterization and production of protein preparations, e.g., therapeutic glycoprotein preparations, are described.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=20161110&CC=WO&NR=2016179397A1&KC=A1

2. METHODS OF GLYCOPROTEIN ANALYSIS 2016-11-10

Abstract: Methods of assessing biosimilarity of proteins, e.g., therapeutic antibodies, are described.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=1&ND=3&adjacent=true&locale=en_EP&FT=D&date=20161110&CC=WO&NR=2016179535A1&KC=A1

3. METHODS OF MANUFACTURING POLYSACCHARIDE COMPOSITIONS

Abstract: Methods of producing, processing, and manufacturing LMWHs.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=2&ND=3&adjacent=true&locale=en_EP&FT=D&date=20161103&CC=US&NR=2016317569A1&KC=A1

4. METHODS OF MANUFACTURING THERAPEUTIC PROTEINS 2016-11-03

Abstract: Disclosed herein are methods of manufacturing therapeutic proteins.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=3&ND=3&adjacent=true&locale=en_EP&FT=D&date=20161103&CC=WO&NR=2016176275A1&KC=A1

5. ANALYSIS OF AMINO ACID COPOLYMER COMPOSITIONS 2016-10-27

Abstract: Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=4&ND=3&adjacent=true&locale=en_EP&FT=D&date=20161027&CC=US&NR=2016312264A1&KC=A1

6. COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC CONSTRUCTS
2015-11-05

Abstract: The present invention relates to compositions and methods of engineered IgG Fc constructs, wherein said Fc constructs include one or more Fc domains.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=5&ND=3&adjacent=true&locale=en_EP&FT=D&date=20151105&CC=CA&NR=2941072A1&KC=A1

7. SIALYLATED GLYCOPROTEINS 2016-09-08

Abstract: Pharmaceutical preparations containing polypeptides having particular sialylation patterns, and methods for the treatment of immune-related thrombocytopenia with such preparations, are described.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=6&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160908&CC=US&NR=2016257754A1&KC=A1

8. METHODS AND COMPOSITIONS FOR MODULATING HAIR GROWTH

Abstract: Methods and compositions related to promoting hair growth are described.

https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=7&ND=3&adjacent=true&locale=en_EP&FT=D&date=20160823&CC=BR&NR=112012031906A2&KC=A2

Intellectual Property

We license or own a patent portfolio of over 70 patent families, each of which includes United States patent applications and/or issued patents as well as foreign counterparts to certain United States patents and patent applications. Our patent portfolio includes issued or pending claims covering:

Methods and technologies for characterizing polysaccharides and other heterogeneous mixtures

The composition of matter and use of certain heparinases, heparinase variants and other enzymes

Methods and technologies for synthesis of polysaccharides

The composition of matter and use of certain novel low molecular weight heparin products, including M402

Methods to identify, analyze and characterize glycoproteins

Methods of manufacture of certain polysaccharide, polypeptide and complex protein or biologic products

http://www.momentapharma.com/technology/intellectual-property.php